New approach could revolutionize the treatment of liver diseases
Researchers from Niigata University , the University of Tokyo, Osaka University and Tokyo Medical University, Japan have developed a new approach that could revolutionize the treatment, prevention, and possibly reversal of the damages caused by liver diseases.
This novel strategy exploits small extracellular vesicles (sEVs) derived from interferon-γ (IFN-γ) pre-conditioned MSCs (γ-sEVs).
Cirrhosis and other chronic liver diseases remain a global health concern, with close to 2 million deaths reported annually, these account for approximately 3.5% of annual worldwide deaths.
All these statistics are largely driven by the fact that 75 million of the 2 billion people who consume alcohol worldwide are diagnosed with alcohol-use disorders and are at risk of developing alcohol- induced liver disease. In addition, the high prevalence of viral hepatitis-induced liver damage continues to be on the rise.
Study finds new weapon in fight against liver diseases
Study finds new weapon in fight against liver diseases
Last Updated: Sun, May 2nd, 2021, 23:20:09hrs
Tokyo [Japan], May 2 (ANI): During a recent study, researchers developed a new approach that could revolutionise the treatment, prevention, and possibly reversal of the damages caused by liver diseases.
The study by researchers from Niigata University, the University of Tokyo, Osaka University and Tokyo Medical University, Japan was published in the journal npj Regenerative Medicine. This novel strategy exploits small extracellular vesicles (sEVs) derived from interferon-g (IFN-g) pre-conditioned MSCs (g-sEVs).
Cirrhosis and other chronic liver diseases remain a global health concern, with close to 2 million deaths reported annually, these account for approximately 3.5 per cent of annual worldwide deaths. All these statistics are largely driven by the fact that 75 million of the 2 billion people who consume alcohol worldwide
Tokyo [Japan], May 2 (ANI): During a recent study, researchers developed a new approach that could revolutionise the treatment, prevention, and possibly reversal of the damages caused by liver diseases.
Niigata University
Niigata, Japan–Researchers from Niigata University , the University of Tokyo, Osaka University and Tokyo Medical University, Japan have developed a new approach that could revolutionize the treatment, prevention, and possibly reversal of the damages caused by liver diseases. This novel strategy exploits small extracellular vesicles (sEVs) derived from interferon-γ (IFN-γ) pre-conditioned MSCs (γ-sEVs).
Cirrhosis and other chronic liver diseases remain a global health concern, with close to 2 million deaths reported annually, these account for approximately 3.5% of annual worldwide deaths. All these statistics are largely driven by the fact that 75 million of the 2 billion people who consume alcohol worldwide are diagnosed with alcohol-use disorders and are at risk of developing alcohol- induced liver disease. In addition, the high prevalence of viral hepatitis-induced liver damage continues to be on the rise.
E-Mail
IMAGE: Increased levels of annexin A1, lactotransferrin, and aminopeptidase N. Increase the counts of anti-inflammatory macrophages with high motility and phagocytic ability, which increase repair of damaged tissue. Induces regulatory T. view more
Credit: Niigata University
Niigata, Japan - Researchers from Niigata University , the University of Tokyo, Osaka University and Tokyo Medical University, Japan have developed a new approach that could revolutionize the treatment, prevention, and possibly reversal of the damages caused by liver diseases. This novel strategy exploits small extracellular vesicles (sEVs) derived from interferon-γ (IFN-γ) pre-conditioned MSCs (γ-sEVs).
Cirrhosis and other chronic liver diseases remain a global health concern, with close to 2 million deaths reported annually, these account for approximately 3.5% of annual worldwide deaths. All these statistics are largely driven by the fact that 75 million of the 2 billion people who c